Prenatal screening enables early assessment of fetal–maternal wellbeing through complimentary modalities, including ultrasonography, non-invasive prenatal screening (NIPS) and quantification of fetal–placental-derived proteins (PAPP-A, FβhCG, AFP, PlGF). We present five cases highlighting the benefits of integrated screening.
Berbic et al. (Sun,) studied this question.